KSC 2020 | 64th Annual Scientific Meeting of The Korean Society of Cardiology

Program at a Glance

Symposium
Scientific Session [Amgen]
The Earlier, The Better: An Ideal Approach with PCSK9 Inhibition in ACS Patients
Oct. 16 (Fri.) 12:00-13:30, Channel 02

12:00 - 12:15

The Importance of LDL-C Lowering with Evolocumab in Recent ACS

[Speaker] Jung-Won Suh/Seoul National Univ.,Korea

12:15 - 12:30

PCSK9 Inhibition: Beyond LDL-C Lowering Effect in ACS Patients

[Speaker] Young-Hoon Jeong/Gyeongsang National Univ.,Korea

12:30 - 12:40

Discussion